Company / CIK 0000886163

Ticker

LGND

Size, estimated from filings

Mid cap ($2B – $10B)

Insiders on file

10

Members of Congress who traded it

1

Federal contracts on record

none matched

Lobbying filings on record

none matched

SEC filings

EDGAR ↗

Latest trade on record

October 2, 2026

Insiders

Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.

Insider transactions

Download CSV258 rows · 92 KB · insider and congressional rows for this ticker · all downloads

Federal contracts (USAspending, awards started in the last 180 days)

No contract award starting in the last 180 days was found for a recipient named exactly "LIGAND PHARMACEUTICALS INC". Subsidiaries and differently-spelled recipients are not matched — search contracts.

Lobbying (Senate LDA, as client)

No LDA filing posted since October 2025 names "LIGAND PHARMACEUTICALS INC" as the client. Filings under a subsidiary or trade-association name are not matched — search lobbying.

Sources and method

Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.

Not investment advice. Public records shown as filed; no recommendation is made or implied.